Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05614544 · ClinicalTrials.gov registry record · Phase 1
Dose-Finding and Human Abuse Potential Study Of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant Users
A Phase 1 study of General Anesthesia, sponsored by Haisco-USA Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT05614544 is a Phase 1 study of General Anesthesia that has completed, run by Haisco-USA Pharmaceuticals. The registered enrollment target is 42 participants, below the 1,628-participant average among 4 other General Anesthesia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05614544, a Phase 1 study of General Anesthesia, has completed, sponsored by Haisco-USA Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
Part 1: To determine the doses of IV HSK3486 and propofol for use in Part 2, the abuse potential part of the study. Part 2: To evaluate the abuse potential of HSK3486 compared with propofol when administered IV to healthy nondependent, recreational CNS depressant drug users.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Propofol
- DRUG HSK3486
Study Locations (1)
Utah
- ICON (LPRA) - Salt Lake - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2022-08-16 |
| Est. Completion | 2023-10-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05614544
The ClinicalTrials.gov registry entry for NCT05614544 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,628-participant average among 4 other General Anesthesia trials with a reported enrollment target (97% lower). The listed sponsor is Haisco-USA Pharmaceuticals, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with General Anesthesia appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT05614544 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT05614544 about?
NCT05614544 is a clinical study titled "Dose-Finding and Human Abuse Potential Study Of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant Users". Part 1: To determine the doses of IV HSK3486 and propofol for use in Part 2, the abuse potential part of the study. Part 2: To evaluate the abuse potential of HSK3486 compared with propofol when administered IV to healthy nondependent, recreational CNS depressant drug users.
What is the current status of trial NCT05614544?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 42 participants. The study started on 2022-08-16. Estimated completion is 2023-10-03.
What conditions does trial NCT05614544 study?
This clinical trial studies the following conditions: General Anesthesia.
What interventions are being tested in trial NCT05614544?
The interventions under investigation include: Placebo (DRUG), Propofol (DRUG), HSK3486 (DRUG).
Who is sponsoring clinical trial NCT05614544?
This trial is sponsored by Haisco-USA Pharmaceuticals, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05614544 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for General Anesthesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Monitoring Exhaled Propofol to Individualize General Anesthesia
COMPLETED · Phase 1
-
Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease
RECRUITING · Phase 4
-
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
RECRUITING
-
Study to Determine if Patients Exposed to General Anesthesia Significant Numbers of Times Would Increase the Risk for Intraoperative Awareness.
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.